Nippon India Pharma Fund Direct Growth

Nippon India Pharma Fund Direct Growth is a Equity Mutual Fund Scheme launched by Nippon India Mutual Fund. This scheme was made available to investors on 02 Jan 2013. The fund currently has an Asset Under Management(AUM) of ₹7,67,506.42 Cr and the Latest NAV as of 16 Jul 2026 is ₹637.53.
The Nippon India Pharma Fund Direct Growth is rated Very High. Minimum SIP Investment is set to ₹100 . Minimum Lumpsum Investment is ₹5,000. Exit load of 1% if redeemed or switched out on or before completion of 1 Months from the date of allotment of units. Nil if redeemed or switched out after the completion of 1 Months from the date of allotment of units..